The U.S. Meals and Drug Administration (FDA) accepted a brand new drug utility (NDA) for zidesamtinib, an investigational ROS1-selective inhibitor meant for...
November brings a time of giving thanks, spending time with household, soccer video games, parades, turkey and the normal pumpkin pie. I particularly keep in...
